Publicaciones (11) Publicaciones de NOELIA PUENTE MONCADA

2024

  1. Endoplasmic reticulum regulation of glucose metabolism in glioma stem cells

    International journal of oncology, Vol. 64, Núm. 1

2023

  1. Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity

    Blood Advances, Vol. 7, Núm. 18, pp. 5382-5395

  2. The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML

    Blood Advances, Vol. 7, Núm. 7, pp. 1204-1218

2022

  1. Calcium acts as a central player in melatonin antitumor activity in sarcoma cells

    Cellular Oncology, Vol. 45, Núm. 3, pp. 415-428

2021

  1. Regulation of cancer cell glucose metabolism is determinant for cancer cell fate after melatonin administration

    Journal of Cellular Physiology, Vol. 236, Núm. 1, pp. 27-40

2020

  1. Role of glucose metabolism in the differential antileukemic effect of melatonin on wild-type and FLT3-ITD mutant cells

    Oncology Reports, Vol. 44, Núm. 1, pp. 293-302

2018

  1. Inhibition of flt3 and pim kinases by ec-70124 exerts potent activity in preclinical models of acute myeloid leukemia

    Molecular Cancer Therapeutics, Vol. 17, Núm. 3, pp. 614-624

2016

  1. Distinct roles of N-acetyl and 5-methoxy groups in the antiproliferative and neuroprotective effects of melatonin

    Molecular and Cellular Endocrinology, Vol. 434, pp. 238-249

2015

  1. Melatonin cytotoxicity is associated to Warburg effect inhibition in Ewing sarcoma cells

    PLoS ONE, Vol. 10, Núm. 8

2014

  1. Involvement of autophagy in melatonin-induced cytotoxicity in glioma-initiating cells

    Journal of Pineal Research, Vol. 57, Núm. 3, pp. 308-316

2013

  1. Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells

    International Journal of Molecular Sciences, Vol. 14, Núm. 4, pp. 6597-6613